Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Updated Phase News

Page 2 - Updated Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Updated Phase. Real-time updates on events, politics, business and more.

AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas

December 12, 2022
Four oral presentations presented at ASH highlight data evaluating investigational epcoritamab for the treatment of relapsed/refractory (R/R) foll...
United States Mohamed Zaki Genmab Duobody Data From The Observational National Lymphocare Study American Society Of Hematology Lymphoma Research Foundation
Source: businessinsider.com

AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas

December 11, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced data from multiple clinical trials evaluating epcoritamab (DuoBody®-CD3xCD20), an investigational...
United States Mohamed Zaki Genmab Duobody Data From The Observational National Lymphocare Study American Society Of Hematology Lymphoma Research Foundation
Source: prnewswire.com

SIGMA LITHIUM ACHIEVES OUTSTANDING PROJECT EXPANSION AND FINANCING MILESTONES: INCREASES MINERAL RESERVES BY 63%, TRIPLES NPV TO US$ 15.3 BILLION AND SECURES US$ 100 MILLION DEBT FINANCING

December 4, 2022
INVESTOR VIDEO CONFERENCE CALL December 6, 2022 at 10AM (EST) Registration Link for Zoom video call below: https://us06web.zoom.us/j/83014247697 Zoom Meeting
United Arab Emirates Minas Gerais British Columbia Sudhir Maheshwari Noel Obrien Marc Antoine Laporte
Source: einnews.com

Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the

November 3, 2022
Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody®-CD3xCD20) in a variety of treatment settings and hematologic malignanciesFour oral presentations highlighting data evaluating epcoritamab for the treatment of relapsed/refractory (R/R) la...
Al Qahirah United States New Orleans New Jersey David Freundel Epcoritamab Duobody
Source: pharmiweb.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)

November 3, 2022
03.11.2022 - Media Release Copenhagen, Denmark, November 3, 2022 Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody-CD3xCD20) in a variety of treatment settings and hematologic ...
Al Qahirah United States New Jersey David Freundel Kalvebod Brygge Epcoritamab Monotherapy
Source: wallstreet-online.de

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)

November 3, 2022
Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody-CD3xCD20) in a variety of treatment settings and hematologic malignancies
Al Qahirah United States New Orleans New Jersey David Freundel Epcoritamab Monotherapy
Source: finanznachrichten.de

Bristol Myers Squibb Research at ESMO Congress 2022 Highlights Depth of Development Program Across Early- and Late-Stages of Cancer

September 5, 2022
05.09.2022 - Bristol Myers Squibb (NYSE: BMY) today announced the presentation of scientific research across several solid tumors showcasing the breadth of the Company’s oncology development program at the European Society for Medical Oncology (ESMO) Congress ...
United States South Korea Tabitha Chan Fadi Diab David Cella Saby George
Source: wallstreet-online.de

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022

June 14, 2022
SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, and IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapie...
United States Hong Kong Innovent Biologics Equecabtagene Autoleucel Chi Adimab Incyte Equecabtagene Autoleucel
Source: singaporestar.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science